tiprankstipranks
Advertisement
Advertisement

SLXN Stock Latest News

Silexion unveils key SIL204 KRAS preclinical findings
Company AnnouncementsSilexion unveils key SIL204 KRAS preclinical findings
8h ago
8K
SLXN
Silexion Therapeutics Restores Nasdaq Audit Committee Compliance
PremiumCompany Announcements
Silexion Therapeutics Restores Nasdaq Audit Committee Compliance
2d ago
8K
SLXN
Silexion Therapeutics Announces Board Member Resignation
PremiumCompany Announcements
Silexion Therapeutics Announces Board Member Resignation
4d ago
8K
SLXN
Silexion Begins Phase 2/3 Trial in Pancreatic Cancer
PremiumCompany Announcements
Silexion Begins Phase 2/3 Trial in Pancreatic Cancer
6d ago
8K
SLXN
Silexion Therapeutics downgraded at Maxim on delisting and dilution risk
PremiumThe Fly
Silexion Therapeutics downgraded at Maxim on delisting and dilution risk
6d ago
SLXN
Silexion Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe FlySilexion Therapeutics downgraded to Hold from Buy at Maxim
6d ago
SLXN
Silexion Activates First Site in Phase 2/3 Trial Targeting KRAS-Driven Pancreatic Cancer (NASDAQ: SLXN)
Premium
TipRanks Newswire
Silexion Activates First Site in Phase 2/3 Trial Targeting KRAS-Driven Pancreatic Cancer (NASDAQ: SLXN)
7d ago
SLXN
Silexion Therapeutics initiates SIL204 trial
Premium
The Fly
Silexion Therapeutics initiates SIL204 trial
7d ago
SLXN
Silexion Therapeutics Shareholders Approve Capital Structure Changes
PremiumCompany Announcements
Silexion Therapeutics Shareholders Approve Capital Structure Changes
14d ago
8K
SLXN
Silexion Therapeutics files to sell 859,609 ordinary shares for holders
PremiumThe Fly
Silexion Therapeutics files to sell 859,609 ordinary shares for holders
2M ago
SLXN
Silexion Therapeutics Implements 1-for-10 Reverse Share Split
PremiumCompany Announcements
Silexion Therapeutics Implements 1-for-10 Reverse Share Split
2M ago
8K
SLXN
Silexion Therapeutics Corp trading halted, news pending
PremiumThe Fly
Silexion Therapeutics Corp trading halted, news pending
2M ago
SLXN
Silexion Therapeutics announces 1-for-10 reverse share split
PremiumThe FlySilexion Therapeutics announces 1-for-10 reverse share split
2M ago
SLXN
Silexion Therapeutics Announces Reverse Split to Maintain Listing
Premium
Company Announcements
Silexion Therapeutics Announces Reverse Split to Maintain Listing
2M ago
8K
SLXN
3 Penny Stocks to Watch Now, 5/21/26
Premium
Market News
3 Penny Stocks to Watch Now, 5/21/26
3M ago
HCWB
MTVA
Silexion Therapeutics Announces Warrant Inducement Financing Agreement
PremiumCompany Announcements
Silexion Therapeutics Announces Warrant Inducement Financing Agreement
3M ago
8K
SLXN
Silexion Announces Positive Preclinical Data for SIL204 Therapy
PremiumCompany Announcements
Silexion Announces Positive Preclinical Data for SIL204 Therapy
3M ago
8K
SLXN
Silexion Therapeutics initiates GMP clinical batch manufacturing of SIL204
PremiumThe Fly
Silexion Therapeutics initiates GMP clinical batch manufacturing of SIL204
3M ago
SLXN
Silexion Advances SIL204 With Manufacturing and Trial Approval
PremiumCompany Announcements
Silexion Advances SIL204 With Manufacturing and Trial Approval
3M ago
8K
SLXN
Silexion Therapeutics Shareholders Approve Capital Increase, Reverse Split
PremiumCompany AnnouncementsSilexion Therapeutics Shareholders Approve Capital Increase, Reverse Split
3M ago
8K
SLXN
Silexion Therapeutics submits SIL204 clinical trial application to Germany
Premium
The Fly
Silexion Therapeutics submits SIL204 clinical trial application to Germany
3M ago
SLXN
Silexion advances SIL204 to EU Phase 2/3 pancreatic trial
Premium
Company Announcements
Silexion advances SIL204 to EU Phase 2/3 pancreatic trial
3M ago
8K
SLXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >